[{"Assets_0_Q2_USD":585109000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-165000.0,"NetIncomeLoss_1_Q2_USD":16588000.0,"NetIncomeLoss_2_Q2_USD":27286000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":34694228.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":34601270.0,"StockholdersEquity_0_Q2_USD":454091000.0,"EarningsPerShareBasic_2_Q2_USD":0.79,"EarningsPerShareBasic_1_Q2_USD":0.48,"Ticker":"PEN","CIK":"1321732","name":"PENUMBRA INC","OfficialName":"Penumbra Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7821675869.0","Country":"nan","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NYSE","SP500":"nan","filed":"20190806"}]